We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 980

Antitrust implication of recent FTC patent related agreement
  • Arnall Golden Gregory LLP
  • USA
  • August 31 2015

In recent years, the Federal Trade Commission (FTC) has refocused its efforts on the interplay between the patent system and antitrust law


Recent appellate FTC cybersecurity ruling
  • Arnall Golden Gregory LLP
  • USA
  • August 27 2015

On August 24, 2015, the United States Court of Appeals for the Third Circuit ruled that the Federal Trade Commission (hereinafter "FTC") has the


Compliance corner: hiring and maintaining a legal workforce
  • Arnall Golden Gregory LLP
  • USA
  • August 25 2015

We're all busy and regardless of your industry, those responsible for hiring our workforce are pulled in many different ways and have to keep abreast


Massachusetts proposes new rules for nursing home sales and closures
  • Arnall Golden Gregory LLP
  • USA
  • August 24 2015

Massachusetts regulators recently announced new rules that, if adopted, will change the requirements for nursing home sales and closures in the state


Another One Bites the Dust: FDA doesn’t like the fishy smell of the latest court decision on off-label dissemination
  • Arnall Golden Gregory LLP
  • USA
  • August 19 2015

The Food and Drug Administration has lost yet another court decision challenging its ability to restrict a company's commercial free speech rights


Life sciences companies and free $& speech
  • Arnall Golden Gregory LLP
  • USA
  • August 19 2015

Irish and NI life sciences companies operating in the US likely are familiar with the concept of "off-label" promotion-providing information about


California’s ICRAA is not unconstitutionally vague
  • Arnall Golden Gregory LLP
  • USA
  • August 18 2015

An appeals court in California recently held that California's Investigative Consumer Reporting Agencies Act (ICRAA) is not unconstitutionally vague


FDA issues guidance to streamline review of 510(k) submissions. A clear path forward?
  • Arnall Golden Gregory LLP
  • USA
  • August 18 2015

On August 4, 2015, the U.S. Food and Drug Administration's (FDA) Center for Devices and Radiological Health released a new guidance document intended


The future of healthcare discrimination litigation-Section 1557 of the ACA
  • Arnall Golden Gregory LLP
  • USA
  • August 17 2015

It is no secret that the Affordable Care Act (ACA) has changed the future of health care in the United States, but in the midst of the ACA's


Six ways for data-driven medical device companies to implement effective privacy and security measures
  • Arnall Golden Gregory LLP
  • USA
  • August 17 2015

The increasing amounts of health information being generated, stored and collected have heightened the special risks medical device manufacturers